Short Interest in Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Expands By 161.2%

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the recipient of a significant increase in short interest during the month of June. As of June 15th, there was short interest totaling 222,527 shares, an increase of 161.2% from the May 31st total of 85,189 shares. Currently, 24.2% of the company’s shares are short sold. Based on an average daily volume of 12,012,243 shares, the short-interest ratio is currently 0.0 days.

Cuprina Holdings (Cayman) Price Performance

Shares of NASDAQ:CUPR opened at $5.33 on Monday. The business has a 50 day moving average price of $2.96. Cuprina Holdings has a 52-week low of $1.76 and a 52-week high of $76.00. The company has a current ratio of 2.35, a quick ratio of 2.35 and a debt-to-equity ratio of 0.07.

Cuprina Holdings (Cayman) (NASDAQ:CUPR) last issued its earnings results on Monday, April 27th. The company reported ($0.40) earnings per share for the quarter. The business had revenue of $0.01 million during the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Cuprina Holdings (Cayman) in a report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

About Cuprina Holdings (Cayman)

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.